As of the 30th of January, Spectral Med has the Coefficient Of Variation of (1,153), risk adjusted performance of (0.06), and Variance of 6.94. Spectral Med technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Spectral, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Spectral
Spectral
Spectral Med's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between Spectral Med's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Spectral Med should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Spectral Med's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Spectral Med 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spectral Med's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spectral Med.
0.00
11/01/2025
No Change 0.00
0.0
In 3 months and 1 day
01/30/2026
0.00
If you would invest 0.00 in Spectral Med on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Spectral Med or generate 0.0% return on investment in Spectral Med over 90 days. Spectral Med is related to or competes with High Tide, Cipher Pharmaceuticals, Aurora Cannabis, Fennec Pharmaceuticals, Canopy Growth, Eupraxia Pharmaceuticals, and Kneat. Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America More
Spectral Med Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spectral Med's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spectral Med upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectral Med's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spectral Med's standard deviation. In reality, there are many statistical measures that can use Spectral Med historical prices to predict the future Spectral Med's volatility.
Spectral Med owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0518, which indicates the firm had a -0.0518 % return per unit of risk over the last 3 months. Spectral Med exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spectral Med's Variance of 6.94, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,153) to confirm the risk estimate we provide. The entity has a beta of -0.5, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Spectral Med are expected to decrease at a much lower rate. During the bear market, Spectral Med is likely to outperform the market. At this point, Spectral Med has a negative expected return of -0.14%. Please make sure to validate Spectral Med's daily balance of power, price action indicator, as well as the relationship between the potential upside and total risk alpha , to decide if Spectral Med performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.36
Poor reverse predictability
Spectral Med has poor reverse predictability. Overlapping area represents the amount of predictability between Spectral Med time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spectral Med price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Spectral Med price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.36
Spearman Rank Test
-0.25
Residual Average
0.0
Price Variance
0.0
Spectral Med technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Spectral Med technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Spectral Med trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Spectral Med Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Spectral Med volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Spectral Med Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Spectral Med on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Spectral Med based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Spectral Med price pattern first instead of the macroeconomic environment surrounding Spectral Med. By analyzing Spectral Med's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Spectral Med's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Spectral Med specific price patterns or momentum indicators. Please read more on our technical analysis page.
Spectral Med January 30, 2026 Technical Indicators
Most technical analysis of Spectral help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Spectral from various momentum indicators to cycle indicators. When you analyze Spectral charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Spectral Med January 30, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Spectral stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.